Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|June 10, 2008
A combination vaccine against measles, mumps, rubella and varicellaMarkus Knuf, Jörg Faber, Immanuel Barth, et al.BMC Medicine|April 16, 2009
Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trialYves Gillet, Pirmin Habermehl, Stéphane Thomas, et al.Human Vaccines|August 11, 2010
Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of agePirmin Habermehl, Geert Leroux-Roels, Roland Sänger, et al.Human Vaccines|April 3, 2008
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulationClaudius U Meyer, Pirmin Habermehl, Markus Knuf, et al.The Journal of Pediatrics|November 11, 2006
Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccineFred Zepp, Markus Knuf, Pirmin Habermehl, et al.Vaccine|June 23, 2007
Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccineFred Zepp, Pirmin Habermehl, Markus Knuf, et al.Medizinische Klinik (Munich, Germany : 1983)|September 17, 2004
Tolerability of the Biken acellular pertussis vaccine in adults with or without previous vaccination against pertussis in childhoodMarkus Knuf, Heinz-J Schmitt, Klaus Mohnike, et al.Clinical and Vaccine Immunology : CVI|February 9, 2007
Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccineHeinz-J Schmitt, Gudrun Maechler, Pirmin Habermehl, et al.Life Sciences|February 9, 2007
The non-neuronal cholinergic system in peripheral blood cells: effects of nicotinic and muscarinic receptor antagonists on phagocytosis, respiratory burst and migrationStefanie Neumann, Michael Razen, Pirmin Habermehl, et al.Pediatric Radiology|November 26, 2002
Biodegradation of tungsten embolisation coils used in childrenChristoph Kampmann, Rita Brzezinska, Moji Abidini, et al.Pageof 2